UBS Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.2M | Buy |
1,695,593
+1,579
| +0.1% | +$86.8K | 0.02% | 819 |
|
|
2025
Q1 | $120M | Buy |
1,694,014
+185,381
| +12% | +$13.1M | 0.02% | 659 |
|
|
2024
Q4 | $99.2M | Buy |
1,508,633
+646,662
| +75% | +$42.5M | 0.02% | 724 |
|
|
2024
Q3 | $60.6M | Buy |
861,971
+476,429
| +124% | +$33.5M | 0.01% | 746 |
|
|
2024
Q2 | $31.7M | Sell |
385,542
-4,670,897
| -92% | -$385M | 0.01% | 982 |
|
|
2024
Q1 | $442M | Buy |
5,056,439
+4,963,987
| +5,369% | +$434M | 0.11% | 139 |
|
|
2023
Q4 | $8.91M | Sell |
92,452
-152,805
| -62% | -$14.7M | ﹤0.01% | 1545 |
|
|
2023
Q3 | $21.7M | Sell |
245,257
-24,719
| -9% | -$2.19M | 0.01% | 995 |
|
|
2023
Q2 | $23.4M | Buy |
269,976
+74,431
| +38% | +$6.45M | 0.01% | 970 |
|
|
2023
Q1 | $19M | Sell |
195,545
-471,739
| -71% | -$45.9M | 0.01% | 1041 |
|
|
2022
Q4 | $69.1M | Sell |
667,284
-437,947
| -40% | -$45.3M | 0.03% | 474 |
|
|
2022
Q3 | $93.7M | Sell |
1,105,231
-1,588,293
| -59% | -$135M | 0.04% | 340 |
|
|
2022
Q2 | $223M | Sell |
2,693,524
-167,979
| -6% | -$13.9M | 0.09% | 195 |
|
|
2022
Q1 | $221M | Buy |
2,861,503
+2,697,524
| +1,645% | +$208M | 0.07% | 212 |
|
|
2021
Q4 | $14.5M | Sell |
163,979
-133,514
| -45% | -$11.8M | ﹤0.01% | 1298 |
|
|
2021
Q3 | $23M | Buy |
297,493
+153,667
| +107% | +$11.9M | 0.01% | 1040 |
|
|
2021
Q2 | $12M | Sell |
143,826
-51,512
| -26% | -$4.3M | ﹤0.01% | 1393 |
|
|
2021
Q1 | $14.8M | Buy |
195,338
+65,250
| +50% | +$4.93M | ﹤0.01% | 1217 |
|
|
2020
Q4 | $11.4M | Buy |
130,088
+45,648
| +54% | +$4M | ﹤0.01% | 1321 |
|
|
2020
Q3 | $6.42M | Sell |
84,440
-40,207
| -32% | -$3.06M | ﹤0.01% | 1534 |
|
|
2020
Q2 | $15.4M | Buy |
124,647
+6,674
| +6% | +$823K | 0.01% | 971 |
|
|
2020
Q1 | $9.97M | Sell |
117,973
-26,296
| -18% | -$2.22M | ﹤0.01% | 1101 |
|
|
2019
Q4 | $12.2M | Sell |
144,269
-153,846
| -52% | -$13M | ﹤0.01% | 1360 |
|
|
2019
Q3 | $20.1M | Buy |
298,115
+149,236
| +100% | +$10.1M | 0.01% | 977 |
|
|
2019
Q2 | $12.8M | Sell |
148,879
-19,346
| -12% | -$1.66M | ﹤0.01% | 1248 |
|
|
2019
Q1 | $14.9M | Buy |
168,225
+9,054
| +6% | +$804K | 0.01% | 1089 |
|
|
2018
Q4 | $13.6M | Sell |
159,171
-11,649
| -7% | -$992K | 0.01% | 1052 |
|
|
2018
Q3 | $16.6M | Buy |
170,820
+55,475
| +48% | +$5.38M | 0.01% | 1059 |
|
|
2018
Q2 | $10.9M | Sell |
115,345
-129,186
| -53% | -$12.2M | ﹤0.01% | 1327 |
|
|
2018
Q1 | $19.8M | Buy |
244,531
+64,143
| +36% | +$5.2M | 0.01% | 913 |
|
|
2017
Q4 | $16.1M | Buy |
180,388
+24,825
| +16% | +$2.21M | 0.01% | 1036 |
|
|
2017
Q3 | $14.5M | Sell |
155,563
-24,469
| -14% | -$2.28M | 0.01% | 1031 |
|
|
2017
Q2 | $16.4M | Buy |
180,032
+20,636
| +13% | +$1.87M | 0.01% | 917 |
|
|
2017
Q1 | $14M | Sell |
159,396
-72,736
| -31% | -$6.38M | 0.01% | 982 |
|
|
2016
Q4 | $19.2M | Sell |
232,132
-71,543
| -24% | -$5.93M | 0.01% | 784 |
|
|
2016
Q3 | $28.1M | Buy |
303,675
+131,344
| +76% | +$12.2M | 0.02% | 599 |
|
|
2016
Q2 | $13.4M | Buy |
172,331
+10,717
| +7% | +$834K | 0.01% | 916 |
|
|
2016
Q1 | $13.3M | Buy |
161,614
+5,160
| +3% | +$426K | 0.01% | 893 |
|
|
2015
Q4 | $16.4M | Sell |
156,454
-49,311
| -24% | -$5.17M | 0.01% | 822 |
|
|
2015
Q3 | $21.7M | Sell |
205,765
-29,515
| -13% | -$3.11M | 0.02% | 666 |
|
|
2015
Q2 | $32.2M | Sell |
235,280
-35,720
| -13% | -$4.89M | 0.02% | 564 |
|
|
2015
Q1 | $33.8M | Buy |
271,000
+123,000
| +83% | +$15.3M | 0.02% | 549 |
|
|
2014
Q4 | $13.4M | Buy |
+148,000
| New | +$13.4M | 0.01% | 981 |
|